openPR Logo
Press release

CNS Therapeutics Market Is Expected To Reach US$ 142.1 Bn By The End Of 2031

10-11-2022 10:00 AM CET | Health & Medicine

Press release from: Fact.MR

The CNS therapeutics market is valued at US$ 116.7 billion in 2022 and is expected to grow to US$ 142.1 billion by the end of 2026. From 2022 to 2026, CNS drug sales are expected to rise at a steady CAGR of 4.9%.

Revenue from CNS drug sales in the United States is expected to reach $36.1 billion by the end of 2026. Furthermore, it takes into consideration the existing development, past events, and recent trends to provide a strong and unbiased opinion on the future direction in which these leading companies will be heading into.

Read Report Overview: https://www.factmr.com/report/cns-therapeutics-market

To back its opinion, the research report covers all the factors and events such as mergers, acquisitions, takeovers, joint ventures, and strategic alliances. It also analyzes the entry barriers and overall intensity of the competition in the global CNS Therapeutics Market.

Competitive Landscape

CNS drug manufacturers are increasing their research and development investments in order to accelerate the development of novel treatment drugs.

Increasing CNS pharmaceutical clinical trials to test drug efficacy will also be critical in the launch of new drugs.

In April 2021, Otsuka Pharmaceuticals Co. Ltd. and H. Lundbeck A/S, two leading names in the CNS therapeutics market, announced the continuation of new patient recruitment for their phase III clinical trials aimed at the treatment of Alzheimer's dementia. The clinical trial investigates the use of brexpiprazole to treat the aforementioned medical condition.

Key Segments Covered in CNS Therapeutics Industry Research

· by Segment:

Pain Management CNS Therapeutics

Anti-psychotics

Anti-depressants

Anti-epilepsy

Anti-Alzheimer's

Anti-Parkinson's

Other Segments

To remain 'ahead' of your competitors, request for a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7292

· by Region:

North America

Latin America

Europe

East Asia

South Asia & Oceania

MEA

Which Regions Should CNS Drug Vendors Monitor?
"North America Will Emerge as a Lucrative Market for CNS Therapeutics"

The market for CNS therapeutics in North America is expected to be extremely profitable over the forecast period. The rising geriatric population and the rising prevalence of CNS diseases are expected to be major factors driving CNS therapeutics market growth in this region.

The United States and Canada are expected to be key markets for CNS drug companies in this region. Government investments and increased awareness of CNS disorders will also favour CNS therapeutics consumption in the aforementioned countries.

Ask an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=7292

The report covers following insights and assessment that are helpful for all participants involved in the CNS Therapeutics market:

Data on recently introduced regulations and their impact on key industries and on demand in the CNS Therapeutics market
Key trends and changing consumer preferences in major industries
Changing demand and consumption of diverse products
Major trends underlining funding by key investors in numerous countries
New investment opportunities in diverse technology and product or service types
Comprehensive data of major players


Reasons to choose a Fact.MR:

Exhaustive research regarding the market to offer A to Z information.
Digital technologies to provide innovative business solutions to clients.
24/7 availability of services.
Interaction with suppliers, vendors, and service providers for a precise market landscape.
Reports tailored as per the requirements of the clients.
Choose Quick and Secure PayPal Payment Mode to Get Full Access to This Report: https://www.factmr.com/checkout/7292

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CNS Therapeutics Market Is Expected To Reach US$ 142.1 Bn By The End Of 2031 here

News-ID: 2763318 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for CNS

CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0] China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province. According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886 This latest report
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibb